OpenURL Connection Search

Select item for more details and to access through your institution.

Porcine alpha-1-antitrypsin (PI): cDNA sequence, polymorphism and assignment to chromosome 7q2.4- > q2.6.
Published in:
Animal Genetics, 1996, v. 27, n. 2, p. 85, doi. 10.1111/j.1365-2052.1996.tb00472.x
By:
- Archibald, A. L.;
- Couperwhite, S.;
- Mellink, C. H. M.;
- Lahbib-Mansais, Y.;
- Gellin, J.
Publication type:
Article
Donor-cell MDS in a 12-year-old girl 3 years after allogeneic hematopoietic SCT for MDS, both with a t(3;3)(q21;q26) cytogenetic aberration.
Published in:
2011
By:
- Leguit, R. J.;
- van den Berg, H.;
- Buijs, A.;
- Mellink, C.;
- Bierings, M.
Publication type:
Letter
Detection of p53 dysfunction in chronic lymphocytic leukaemia cells through multiplex quantification of p53 target gene induction.
Published in:
2009
By:
- Mous, R.;
- Jaspers, A.;
- Luijks, D. M. P.;
- Mellink, C. H. M.;
- van Oers, M. H. J.;
- Kater, A. P.;
- Eldering, E.
Publication type:
Letter
Atypical 11q deletions identified by array CGH may be missed by FISH panels for prognostic markers in chronic lymphocytic leukemia.
Published in:
2009
By:
- Gunn, S. R.;
- Hibbard, M. K.;
- Ismail, S. H.;
- Lowery-Nordberg, M.;
- Mellink, C. H. M.;
- Bahler, D. W.;
- Abruzzo, L. V.;
- Enriquez, E. L.;
- Gorre, M. E.;
- Mohammed, M. S.;
- Robetorye, R. S.
Publication type:
Letter
MURANO: Final 7 year follow up and retreatment analysis in venetoclax‐rituximab (VenR)‐treated patients with relapsed/refractory chronic lymphocytic leukemia (R/R CLL).
Published in:
Hematological Oncology, 2023, v. 41, p. 239, doi. 10.1002/hon.3163_156
By:
- Kater, A. P.;
- Harrup, R.;
- Kipps, T. J.;
- Eichhorst, B.;
- Owen, C. J.;
- Assouline, S.;
- Lamanna, N.;
- Robak, T.;
- Serna, J. d. l.;
- Jaeger, U.;
- Cartron, G.;
- Montillo, M.;
- Mellink, C.;
- Chyla, B.;
- Thadani‐Mulero, M.;
- Lefebure, M.;
- Jiang, Y.;
- Millen, R.;
- Boyer, M.;
- Seymour, J. F.
Publication type:
Article
UNFAVORABLE GENETICS IMPACT MRD RESPONSE TO VENETOCLAX+RITUXIMAB RETREATMENT IN RELAPSED OR REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA (R/R CLL): PHASE 3 MURANO SUBSTUDY.
Published in:
Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.50_2880
By:
- Wu, J. Q.;
- Seymour, J. F.;
- Eichhorst, B.;
- Hillmen, P.;
- Kipps, T.;
- Langerak, A. W.;
- Owen, C.;
- Dubois, J.;
- Mellink, C.;
- van der Kevie‐Kersemaekers, A.;
- Chyla, B.;
- Jiang, Y.;
- Boyer, M.;
- Thadani‐Mulero, M.;
- Lefebure, M.;
- Kater, A. P.
Publication type:
Article
IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 106, doi. 10.1002/hon.69_2629
By:
- Wu, J.;
- Bolen, C.;
- Seymour, J.F.;
- Hillmen, P.;
- Eichhorst, B.;
- Eldering, E.;
- Kipps, T.J.;
- Langerak, A.W.;
- Mellink, C.;
- Kevie‐Kersemaekers, A.F.;
- Owen, C.;
- Chyla, B.;
- Punnoose, E.A.;
- Wang, J.;
- Boyer, M.;
- Humphrey, K.;
- Jiang, Y.;
- Kater, A.P.
Publication type:
Article
IMPACT OF MAJOR GENOMIC ALTERATIONS ON OUTCOME OF RELAPSED/REFRACTORY CHRONIC LYMPHOCYTIC LEUKEMIA PATIENTS RECEIVING VENETOCLAX PLUS RITUXIMAB IN THE PHASE 3 MURANO STUDY.
Published in:
Hematological Oncology, 2019, v. 37, p. 106, doi. 10.1002/hon.69_2629
By:
- Wu, J.;
- Bolen, C.;
- Seymour, J.F.;
- Hillmen, P.;
- Eichhorst, B.;
- Eldering, E.;
- Kipps, T.J.;
- Langerak, A.W.;
- Mellink, C.;
- Kevie‐Kersemaekers, A.F.;
- Owen, C.;
- Chyla, B.;
- Punnoose, E.A.;
- Wang, J.;
- Boyer, M.;
- Humphrey, K.;
- Jiang, Y.;
- Kater, A.P.
Publication type:
Article
Numerical variation of nucleolar organizer regions after silver staining in domestic and wild Suidae (Mammalia).
Published in:
Animal Genetics, 1992, v. 23, n. 3, p. 231, doi. 10.1111/j.1365-2052.1992.tb00135.x
By:
- MELLINK, C. H. M.;
- BOSMA, A. A.;
- HAAN, N. A.;
- MACDONALD, A. A.
Publication type:
Article

Found: 9